会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    • 2-(亚氨基甲基)氨基 - 苯基的衍生物,它们的制备,它们作为药物的用途以及含有它们的药物组合物
    • US06809088B2
    • 2004-10-26
    • US10191950
    • 2002-07-09
    • Pierre Etienne Chabrier de LassauniereSerge AuvinDennis BiggMichel AuguetJeremiah Harnett
    • Pierre Etienne Chabrier de LassauniereSerge AuvinDennis BiggMichel AuguetJeremiah Harnett
    • A61K3133
    • C07D333/34C07D333/38C07D409/12C07D417/12
    • The invention relates to new derivatives of 2-(iminomethyl)amino-phenyl which are NO synthase inhibitors and can trap reactive oxygen species. These compounds can notably be used for the treatment of stroke, of neurodegenerative diseases and of ischemic or hemorragic cardiac or cerebral infarctions. These compounds include: N-{4-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2-carboximidamide; N-{3-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2-carboximidamide; N-(4-{[{[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}(methyl)amino]methyl}phenyl)thiophene-2-carboximidamide; N-[3-({[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-(3-{[(3,5-di-tert-butyl-4-hydroxybenzyl)amino]methyl}phenyl)thiophene-2-carboximidamide; N-[3-({[2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-[3-({[3-(4-hydroxy-3,5-diisopropylphenyl)propyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-(3-{[(4-hydroxy-3,5-diisopropylbenzyl)amino]methyl}phenyl) thiophene-2-carboximidamide; N-[3-({[2-(4-hydroxy-3,5-diisopropylphenyl)ethyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-2-(3,5-di-tert-butyl-4-hydroxybenzoyl)-N-1-(4-{[imino(thien-2-yl)methyl]amino}phenyl)-L-leucinamide; and pharmaceutically acceptable salts thereof.
    • 本发明涉及作为NO合酶抑制剂的2-(亚氨基甲基)氨基 - 苯基的新衍生物,并可捕获活性氧。 这些化合物可以显着地用于治疗中风,神经变性疾病和缺血性或血液性心脏病或脑梗塞。这些化合物包括:N- {4 - [({[4-(3,5-二叔丁基 -4-羟基苯基)-1,3-噻唑-2-基]甲基}氨基)甲基]苯基}噻吩-2-甲脒; N- {3 - [({[4-(3,5-二 - 丁基-4-羟基苯基)-1,3-噻唑-2-基]甲基}氨基)甲基]苯基}噻吩-2-甲脒; N-(4 - {[{[4-(3,5-二叔丁基 (3-(3,5-二叔丁基-4-羟基苯基)-1,3-噻唑-2-基]甲基}(甲基)氨基]甲基}苯基)噻吩-2-甲脒; N-〔3 - 二 - 叔丁基-4-羟基苯基)丙基]氨基}甲基)苯基]噻吩-2-甲脒; N-(3 - {[(3,5-二叔丁基-4-羟基苄基)氨基]甲基} 苯基)噻吩-2-甲脒; N- [3 - ({[2-(3,5-二叔丁基-4-羟基苯基)乙基]氨基}甲基)苯基]噻吩-2-甲脒; N- [ 3 - ({[3-(4-羟基-3,5-二异丙基苯基)丙基]氨基}甲基)苯基]噻吩-2-甲脒; N-(3 - {[(4-羟基-3,5-二异丙基苄基) 氨基]甲基}苯基)硫代 2- [3 - ({[2-(4-羟基-3,5-二异丙基苯基)乙基]氨基}甲基)苯基]噻吩-2-亚甲代酰胺; N-2- 二 - 叔丁基-4-羟基苯甲酰基)-N-1-(4 - {[亚氨基(噻吩-2-基)甲基]氨基}苯基)-L-亮氨酰胺;及其药学上可接受的盐。
    • 7. 发明授权
    • Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    • 2-(亚氨基甲基)氨基 - 苯基的衍生物,它们的制备,它们作为药物的用途以及含有它们的药物组合物
    • US07553976B2
    • 2009-06-30
    • US12009742
    • 2008-01-22
    • Pierre Etienne Chabrier De LassauniereSerge AuvinDennis BiggMichel AuquetJeremiah Harnett
    • Pierre Etienne Chabrier De LassauniereSerge AuvinDennis BiggMichel AuquetJeremiah Harnett
    • C07D277/28
    • C07D333/34C07D333/38C07D409/12C07D417/12
    • The invention relates to new derivatives of 2-(iminomethyl)amino-phenyl which are NO synthase inhibitors and can trap reactive oxygen species. These compounds can notably be used for the treatment of stroke, of neurodegenerative diseases and of ischemic or hemorragic cardiac of cerebral infarctions.These compounds include: N-{4-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2-carboximidamide; N-{3-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl-)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2carboximidamide; N-(4-{[{[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}(methyl)amino]methyl}phenyl)thiophene-2carboximidamide; N-[3-(}[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]amino}methyl) phenyl]thiophene-2carboximidamide; N-(3-{[(3,5-di-tert-butyl-4-hydroxybenzyl)amino]methyl}phenyl)thiophene-2-carboximidamide; N-[3-({[2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-[3-({[3-(4-hydroxy-3,5-diisopropylphenyl)propyl]amino}methyl)phenyl]thiophene -2-carboximidamide; N-(3-{[(4-hydroxy-3,5-diisopropylbenzyl)amino]phenyl)thiophene-2- carboximidamide; N-[3-({[2-(4-hydroxy-3,5-diisopropylphenyl)ethyl]amino}methyl) phenyl]thiophene-2-carboximidamide; N-2-(3,5-di-tert-butyl-4-hydroxybenzoyl)-N-1(4-(4-{[imino(thien-2-yl) methyl]amino}phenyl)-L-leucinamide; and pharmaceutically acceptable salts thereof.
    • 本发明涉及作为NO合酶抑制剂的2-(亚氨基甲基)氨基 - 苯基的新衍生物,并可捕获活性氧。 这些化合物可以显着地用于治疗中风,神经变性疾病和脑梗死的缺血性或血液性脑损伤。 这些化合物包括:N- {4 - [({[4-(3,5-二叔丁基-4-羟基苯基)-1,3-噻唑-2-基]甲基}氨基)甲基]苯基}噻吩 -2-甲脒 N- {3 - [({[4-(3,5-二叔丁基-4-羟基苯基)-1,3-噻唑-2-基]甲基}氨基)甲基]苯基}噻吩-2-甲酰胺; N-(4 - {[{[4-(3,5-二叔丁基-4-羟基苯基)-1,3-噻唑-2-基]甲基}(甲基)氨基]甲基}苯基)噻吩 - 2卡泊酰胺; N- [3 - ({[3-(3,5-二叔丁基-4-羟基苯基)丙基]氨基}甲基)苯基]噻吩-2-甲酰胺; 噻唑-2-甲酰胺; N-(3 - {[(3,5-二叔丁基-4-羟基苄基)氨基]甲基}苯基)噻吩-2-甲脒; N- [3 - ({[2-(3,5-二叔丁基-4-羟基苯基)乙基]氨基}甲基)苯基]噻吩-2-甲脒; N- [3 - ({[3-(4-羟基-3,5-二异丙基苯基)丙基]氨基}甲基)苯基]噻吩-2-甲脒; N-(3 - {[(4-羟基-3,5-二异丙基苄基)氨基]苯基)噻吩-2-甲脒; N- [3 - ({[2-(4-羟基-3,5-二异丙基苯基)乙基]氨基}甲基)苯基]噻吩-2-甲脒; N-2-(3,5-二叔丁基-4-羟基苯甲酰基)-N-1(4-(4 - {[亚氨基(噻吩-2-基)甲基]氨基}苯基)-L-亮氨酰胺; 及其药学上可接受的盐。